Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →
CLEATUS
Get CLEATUS

Notice of Change in Application Due Date for PAR-25-032 "NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)"

Active
NOT-HL-27-003Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Heart, Lung, and Blood Institute has issued a notice regarding changes to the Notice of Funding Opportunity PAR-25-032 for Clinical Trial Pilot Studies. The primary purpose of this update is to extend the availability of the funding opportunity by adding an additional receipt date for new applications as well as resubmission and revision applications. As a result of these changes, the expiration date for the NOFO has been moved to March 17, 2027. All other terms, conditions, and requirements of the original solicitation remain unchanged. Applicants are reminded that all submissions must be received by 5:00 PM local time of the applicant organization.

General Info

NHLBI extended the PAR-25-032 funding opportunity expiration date to March 17, 2027.

Agency

National Institutes Of Health → National Heart, Lung, And Blood Institute

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

Contract opportunity posted

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Institutes Of Health → National Heart, Lung, And Blood Institute
Contacts6 people available
OfficeUSA
Organization / AgencyNational Institutes Of Health → National Heart, Lung, And Blood Institute
Office AddressUSA
Contacts
Division of Cardiovascular SciencesNational Heart, Lung, and Blood Institute (NHLBI)
contact@example.gov
Division of Blood Diseases and Resources Grant Resources (Non-Clinical Trial ResearchNational Heart, Lung, and Blood Institute (NHLBI)
contact@example.gov
Division of Blood Diseases and Resources Clinical TrialsNational Heart, Lung, and Blood Institute (NHLBI)
contact@example.gov
Division of Lung DiseasesNational Heart, Lung, and Blood Institute (NHLBI)
contact@example.gov
Center for Translation Research and Implementation ScienceNational Heart, Lung, and Blood Institute (NHLBI)
contact@example.gov
Office of Grants ManagementNational Heart, Lung, and Blood Institute (NHLBI)
contact@example.gov

Full Description

Show more
The purpose of this notice is to inform potential applicants of a change in the key dates for the Notice of Funding Opportunity (NOFO) PAR-25-032 "NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)". Specifically, 1 additional receipt date has been added for new applications and resubmission/revision applications. The NOFO will now expire on March 17, 2027. The following sections of PAR-25-032 have been updated in bold italics to reflect the additional receipt dates and new expiration date. Currently Reads Part 1. Overview Information Key Dates The following table includes NIH standard due dates marked with an asterisk. Application Due Dates Review and Award Cycles New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date February 16, 2025 * March 16, 2025 * May 07, 2025 * July 2025 October 2025 December 2025 June 16, 2025 * July 16, 2025 * September 07, 2025 * November 2025 January 2026 April 2026 October 16, 2025 * November 16, 2025 * January 07, 2026 * March 2026 May 2026 July 2026 February 16, 2026 * March 16, 2026 * May 07, 2026 * July 2026 October 2026 December 2026 June 16, 2026 * July 16, 2026 * Not Applicable November 2026 January 2027 April 2027 October 16, 2026 * November 16, 2026 * Not Applicable March 2027 May 2027 July 2027 All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Expiration Date January 08, 2027 Due Dates for E.O. 12372 Not Applicable Revised to Read Part 1. Overview Information Key Dates The following table includes NIH standard due dates marked with an asterisk. Application Due Dates Review and Award Cycles New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date February 16, 2025 * March 16, 2025 * May 07, 2025 * July 2025 October 2025 December 2025 June 16, 2025 * July 16, 2025 * September 07, 2025 * November 2025 January 2026 April 2026 October 16, 2025 * November 16, 2025 * January 07, 2026 * March 2026 May 2026 July 2026 February 16, 2026 * March 16, 2026 * May 07, 2026 * July 2026 October 2026 December 2026 June 16, 2026 * July 16, 2026 * Not Applicable November 2026 January 2027 April 2027 October 16, 2026 * November 16, 2026 * Not Applicable March 2027 May 2027 July 2027 February 16, 2027 * March 16, 2027 * Not Applicable July 2027 October 2027 December 2027 All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Expiration Date March 17, 2027 Due Dates for E.O. 12372 Not Applicable All other aspects of the NOFO remain the same.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Grant
Notice of Change in Application Due Date for NHLBI NOFOs PAR-25-025 and PAR-25-026
Solicitation # NOT-HL-27-002
This notice announces updates to the key dates for two National Heart, Lung, and Blood Institute funding opportunities, PAR-25-025 and PAR-25-026. These opportunities support early phase clinical trials for therapeutics and diagnostics related to heart, lung, and blood disorders. The primary purpose of the update is to add one additional receipt date for new applications as well as resubmission and revision applications. As a result of these changes, the expiration date for both notices of funding opportunity has been extended to February 4, 2027. A new application deadline has been established for February 3, 2027, with a corresponding earliest start date of December 2027. All other terms, conditions, and requirements of the original funding opportunities remain unchanged.
National Heart, Lung, And Blood Institute

POSTED

about 21 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Notice of NHLBI Withdrawal from Participation in PA-25-305 "NIH Research Project Grant (Parent R01 Clinical Trial Required)"
Solicitation # NOT-HL-27-001
This notice announces that the National Heart, Lung, and Blood Institute (NHLBI) will withdraw its participation from the NIH Research Project Grant PA-25-305, which requires clinical trials. This withdrawal becomes effective for all application due dates occurring after July 5, 2026. While the NHLBI is exiting this specific funding opportunity, all other participating NIH organizations and institutes remain involved. No other terms or conditions of the original notice of funding opportunity have been changed.
National Heart, Lung, And Blood Institute

POSTED

about 22 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Notice of NIDCR Participation in PA-25-302, NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Solicitation # NOT-DE-27-001
The National Institute of Dental and Craniofacial Research (NIDCR) has announced its participation in the NIH Small Research Grant Program, specifically under the Notice of Funding Opportunity PA-25-302. This program, which does not allow clinical trials, is effective for application due dates on or after February 16, 2027. The NIDCR joins a wide array of other NIH institutes and centers, including the National Cancer Institute and the National Center for Advancing Translational Sciences, in offering this funding opportunity. All submitted applications must align with the specific missions of the participating Institutes or Centers. Additionally, the Office of Data Science Strategy may provide co-funding for assigned applications. While the list of participating organizations and associated assistance listing numbers has been updated to include the NIDCR, all other terms and conditions of the original funding opportunity remain unchanged.
National Institute Of Dental And Craniofacial Research

POSTED

about 22 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Space & Ground Systems Engineering (V&V and Troubleshooting)This subcontract opportunity with the Department of the Air Force focuses on providing specialized systems engineering support for prime contractors working on Space Rapid Capabilities Office projects. The scope of work centers on the verification and validation of interface requirements, hardware integration and testing, and the execution of on-orbit troubleshooting for payloads on host vehicles. To ensure mission success, the contractor will utilize integration test beds and adhere to strict V&V standards. Key deliverables for this effort include comprehensive V&V reports, detailed integration test results, and anomaly resolution reports. The work is designated under NAICS code 541715 and is slated for performance in Dayton. Interested parties must submit their responses by the deadline of November 4, 2026.
Department Of The Air Force

POSTED

about 23 hours ago

DEADLINE

in 14 days
View Details
NAICS: 541715
New
Federal
Custom Synthesis of SYK Inhibitors (S1115 and S1213)
National Institutes Of Health Olao

POSTED

about 23 hours ago

DEADLINE

in 14 days
View Details
NAICS: 541715
New
Federal
Academic and Research PartnersThe Academic and Research Partners subcontract supports the USMC Department of Defense by providing foundational research and conceptual development for prime contractors on PM TRASYS training systems projects. The scope of work involves identifying innovative commercial concepts, developing technical briefs, and validating technology maturity levels. Eligible participants must operate as academic institutions or Non-Traditional Defense Contractors. Key deliverables for this engagement include research reports, technical white papers, and validated concept demonstrations. The contract is categorized under NAICS code 541715 and remains open for responses until October 19, 2031.
USMC

POSTED

about 23 hours ago

DEADLINE

in almost 5 years
View Details
NAICS: 541715
New
Federal
Commercial Technology Providers (General AoI)This subcontract opportunity, titled Commercial Technology Providers (General AoI), seeks partners to supply and integrate mature or emerging commercial technologies for prime contractors supporting PM TRASYS training systems projects. The scope of work involves executing agile development activities, pilots, and concept demonstrations designed to address specific training gaps. Selected providers must deliver functional commercial solutions or prototypes that are fully integrated into Department of the Army or Defense systems. Managed under the USMC and Department of Defense, the contract emphasizes the need for long-term sustainability and integration readiness. The performance period extends through October 19, 2031, with the primary focus falling under NAICS code 541715 for research and development in the physical, engineering, and life sciences.
USMC

POSTED

about 23 hours ago

DEADLINE

in almost 5 years
View Details
NAICS: 541715
New
Federal
Critical Infrastructure Modeling Specialist
Defense Advanced Research Projects Agcy

POSTED

about 23 hours ago

DEADLINE

in 17 days
View Details
NAICS: 541715
New
Federal
Nassau Proposers Day
Solicitation # DARPA-SN-27-08
The Defense Advanced Research Projects Agency's Information Processing Techniques Office is hosting a Proposers Day for the anticipated Nassau program, a critical infrastructure resilience initiative. This event, identified by special notice DARPA-SN-27-08, is designed to provide potential proposers with technical goals and challenges associated with the program. The Nassau program is divided into two technical areas: Technical Area 1 focuses on modeling a specific class of critical infrastructure, while Technical Area 2 contains restricted information available only via a classified SECRET addendum. This notice is for informational and planning purposes and does not constitute a formal solicitation for proposals. Interested organizations must meet stringent security and cybersecurity standards to access program addendums. For the Controlled Unclassified Information addendum, organizations must provide a Supplier Performance Risk System affirmation of CMMC level 2 compliance and adhere to NIST SP 800-171, DoDI 8582.01, and DFARS 252.204-7021 safeguarding requirements. Those seeking the classified addendum must possess a valid SECRET or higher Facility Clearance Letter from the Defense Counterintelligence and Security Agency and have access to SAV, JWICS, or DSWAN networks. Requests for the CUI addendum must be submitted by November 2, 2026, with the anticipated release of addendums occurring on December 10, 2026.
Defense Advanced Research Projects Agcy

POSTED

about 23 hours ago

DEADLINE

in 17 days
View Details
NAICS: 541715
New
Federal
ARMY APPLICATIONS LABORATORY BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE TECHNOLOGIES
Solicitation # W911NF-24-S-0008
The United States Army Futures Command, through the Army Applications Lab, has issued Broad Agency Announcement W911NF-24-S-0008 to solicit disruptive technology applications. This initiative aims to modernize the Army by leveraging civilian research, development, and innovation ecosystems to create a first-mover advantage. The program focuses on seven key priorities: Long-Range Precision Fires, Next Generation Combat Vehicles, Future Vertical Lift Platforms, the Army Network, Air and Missile Defense Capabilities, Soldier Lethality, and Contested Logistics. The effort is structured around three main lines of action: the discovery of novel capability concepts, the acceleration of technology demonstrators that provide a significant improvement over current capabilities, and the translation of these innovations into scalable Army advantages. The Army is specifically seeking advancements in Fourth Industrial Revolution technologies, including artificial intelligence, robotics, autonomy, quantum information systems, synthetic biology, and advanced power and energy systems. There is a strong emphasis on translational research and the development of dual-use solutions that serve both military needs and commercial markets. This solicitation, managed by the Army Contracting Command in Research Triangle Park, North Carolina, remains active from April 5, 2024, through April 5, 2029, with performance centered in Austin, Texas.
W6QK Acc-Apg Durham

POSTED

about 23 hours ago

DEADLINE

in over 2 years
View Details
NAICS: 541715
New
Federal
Call 03 M-DASH - Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II)
Solicitation # FA238426SB007
The Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II) project, specifically the Multi-Decision Advantage Sprint for Human-Machine Teaming (M-DASH), is a research effort led by the Air Force Research Laboratory. The program aims to develop Human-Machine Teaming concepts and AI/automation capabilities to provide Battle Managers with decision advantage within the Combined Joint All-Domain Command and Control (CJADC2) framework. The effort focuses on the Transformational Model for Decision Advantage (TM-DA) to bridge the gap between operational concepts and software design, specifically requiring solutions that address three decision services: PAE, MEF, and GBC. The M-DASH event is a two-week simulation sprint scheduled for January 25 to February 5, 2027, in Las Vegas, Nevada. The government anticipates awarding Firm Fixed Price contracts or Other Transaction agreements with a maximum value of 100,000 dollars per selected offeror, out of a total estimated program cost of 600,000 dollars. Payment is issued as a single sum upon the conclusion of the event and the successful delivery of a Technical Review Presentation Package, which must include an end-of-event presentation, a technology survey, and simulated run digital audit logs. Eligibility for award requires offerors to have a CMMC Level 1 Self assessment and undergo a rigorous Science and Technology Protection risk review for all senior and key personnel. Proposals were due by October 21, 2026, and were subject to strict page limits for both the proposal and the Statement of Work. All deliverables must be submitted electronically to a government-controlled repository, and contractors must comply with AFRL supplemental requirements regarding patent rights, CUI marking, and security risk disclosures.
FA2384 USAF Afmc Afrl Pzl Afrl Rakh

POSTED

about 23 hours ago

DEADLINE

in about 10 hours
View Details
NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 23 hours ago

DEADLINE

in 11 months
View Details

More opportunities from National Institutes Of Health → National Heart, Lung, And Blood Institute

Same awarding agency

NAICS: 541715
Grant
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
Solicitation # RFA-HL-27-010
The Stimulating Access to Research in Residency Transition Scholar (StARRTS) K38 Career Development program, issued by the National Heart, Lung, and Blood Institute under solicitation RFA-HL-27-010, is designed to retain and support clinician-investigators who have completed the StARR R38 Program. By providing grants to Transition Scholars, the program facilitates continued research and career development in basic, clinical, or translational fields during clinical fellowships or early faculty appointments. The ultimate goal is to create a sustainable pathway that accelerates the transition of these individuals into independent research careers. This is a limited competition opportunity open to eligible organizations, with applications subject to the standard NIH peer-review process to ensure only meritorious projects are funded. The solicitation was posted on October 9, 2026, and has a response deadline of October 14, 2028. Clinical trials are not allowed under this specific K38 funding mechanism.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in almost 2 years
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS